Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Flunarizine Hydrochloride Dispersible Tablets
- Product Name
- 盐酸氟桂利嗪分散片
- Approval Number
- 国药准字H20080275
- Approval Date
- May 2, 2023
NMPA
Lumbrokinase Enteric-coated Capsules
- Product Name
- 普恩复
- Approval Number
- 国药准字H20068081
- Approval Date
- Jan 16, 2020
NMPA
Lumbrokinase Enteric-coated Capsules
- Product Name
- 普恩复
- Approval Number
- 国药准字H37022072
- Approval Date
- Jan 16, 2020
NMPA
Pefloxacin Mesylate Capsules
- Product Name
- 甲磺酸培氟沙星胶囊
- Approval Number
- 国药准字H10960127
- Approval Date
- Jan 16, 2020
NMPA
Procaterol Hydrochloride Tablets
- Product Name
- 盐酸丙卡特罗片
- Approval Number
- 国药准字H19994101
- Approval Date
- Jan 16, 2020
NMPA
Clinical Trials
No trials found
News
No news found